1 / 7

Stimulating Medical Innovation HHS Task Force

Stimulating Medical Innovation HHS Task Force. Larry Kessler, Sc.D. Task Force Executive Director Director, Office of Science and Engineering Laboratories, CDRH, FDA. Task Force Goals.

lynne
Download Presentation

Stimulating Medical Innovation HHS Task Force

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Stimulating Medical InnovationHHS Task Force Larry Kessler, Sc.D. Task Force Executive Director Director, Office of Science and Engineering Laboratories, CDRH, FDA

  2. Task Force Goals • Weigh new ideas and promote new solutions to encourage innovation in health care and to speed the development of effective new medical technologies, such as drug and biological products and medical devices • Will issue a report this year on appropriate steps that can be taken across the department to speed the development and availability of new medical technologies

  3. Task Force Members • Chair: Lester M. Crawford, D.V.M., Ph.D., Commissioner of Food & Drugs (Actg) • Principal Members • Elias Zerhouni, M.D., Director, National Institutes of Health • Mark B. McClellan, M.D., Ph.D., Director, Centers for Medicaid Services • Julie Gerberding, M.D., Director, Centers for Disease Control & Prevention • Andrew Von Eschenbach, M.D., Director, National Cancer Institute, NIH

  4. Task Force Workers • Larry Kessler, Sc.D., FDA, Executive Director • Nancy Stanisic, FDA, Project Manager • Howard Zucker, OS, Point of Contact • Tom Kuchenberg, OS • Daniel Sullivan, NCI/NIH • Vadim Lubarsky, CMS • Shana Christrup, CDC • Elise Berliner, AHRQ • Angela Hight-Walker, NIST

  5. Two Approaches • Find ways in which HHS Agencies can better coordinate efforts to speed technology from discovery to delivery; these should complement the FDA Critical Path, NIH Roadmap, other initiatives • Locate other non-HHS Agencies that play a significant role in the development of cutting edge medical technology and improve collaboration with HHS

  6. Selected Ideas from the Docket • Facilitating biomarker development • More informative development programs and data • Streamlining HHS involvement in technology (replicate ICBIO model) • Facilitate In Vitro Diagnostic Development • Facilitate Antibiotic Development • Cross Training Technology Transfer in HHS

  7. Organizations for Collaboration • National Institute on Standards and Technology (NIST) • Defense Science Office (DARPA) • Telemedicine and Advanced Techonlogy Research Center (TATRC) • National Science Foundation (NSF) • National Institute on Disability and Rehabilitation Research (NIDRR – Dept Ed) • Veterans Administration (VA)

More Related